CCL2 and leukemia: This monoterpene also exhibited an anti-inflammatory effect via the inhibition of some signaling pathways leading to the inflammatory process in leukemia (HL-60) cell lines, such as ROS, monocyte chemoattractant protein-1 (MCP-1), NF-κB, and p38 mitogen-activated protein kinase (MAPK) [37].